Impfung gegen humane Papillomaviren (HPV) zur Prävention HPV 16/18 induzierter Zervixkarzinome und derer Vorstufen
O Damm, M Nocon, S Roll, C Vauth… - GMS Health …, 2009 - repo.uni-hannover.de
Introduction: Essential precondition for the development of cervical cancer is a persistent
human papillomavirus (HPV) infection. The majority-approximately 70%-of cervical …
human papillomavirus (HPV) infection. The majority-approximately 70%-of cervical …
Extending the human papillomavirus vaccination programme to include males in high-income countries: a systematic review of the cost-effectiveness studies
MB Ben Hadj Yahia, A Jouin-Bortolotti… - Clinical drug …, 2015 - Springer
Abstract Background and Objectives Giving the human papillomavirus (HPV) vaccination to
females has been shown to be cost-effective in most countries. The epidemiological …
females has been shown to be cost-effective in most countries. The epidemiological …
Effectiveness of HPV vaccines against genital warts in women from Valencia, Spain
E Navarro-Illana, M López-Lacort, P Navarro-Illana… - Vaccine, 2017 - Elsevier
Objectives To assess the effectiveness of the HPV vaccines in preventing genital warts in
young women. Design Population-based study using health databases. Setting Valencian …
young women. Design Population-based study using health databases. Setting Valencian …
Universal vaccination with the quadrivalent HPV vaccine in Austria: impact on virus circulation, public health and cost–effectiveness analysis
X Bresse, C Goergen, B Prager… - Expert review of …, 2014 - Taylor & Francis
The International Agency for Research on Cancer acknowledges that HPV is a human
carcinogen affecting both sexes. This study aimed to evaluate the public health impact of …
carcinogen affecting both sexes. This study aimed to evaluate the public health impact of …
Impact of quadrivalent human papillomavirus vaccine on genital warts in an opportunistic vaccination structure
S Lurie, Y Mizrachi, G Chodick, R Katz, E Schejter - Gynecologic oncology, 2017 - Elsevier
Objective Genital warts are the most common sexually transmitted disease and have a
detrimental impact on quality of life. Genital warts could be prevented by prophylactic HPV …
detrimental impact on quality of life. Genital warts could be prevented by prophylactic HPV …
Genital warts in men: a large population-based cross-sectional survey of Danish men
C Munk, A Nielsen, KL Liaw, SK Kjaer - Sexually transmitted infections, 2012 - sti.bmj.com
Objectives To estimate the occurrence of and risk factors associated with genital warts in
Danish men Methods We conducted a cross-sectional, questionnaire-based study among …
Danish men Methods We conducted a cross-sectional, questionnaire-based study among …
Trends in genital warts diagnoses in New Zealand five years following the quadrivalent human papillomavirus vaccine introduction
J Oliphant, J Stewart, P Saxton, M Lo… - The New Zealand …, 2017 - search.proquest.com
AIM: To investigate whether changes in rates of genital warts diagnosis at Auckland Sexual
Health Service (ASHS), pre and post the quadrivalent human papillomavirus (4vHPV) …
Health Service (ASHS), pre and post the quadrivalent human papillomavirus (4vHPV) …
[HTML][HTML] Revisiting the cost-effectiveness of universal HPV-vaccination in Denmark accounting for all potentially vaccine preventable HPV-related diseases in males …
J Olsen, TR Jørgensen - Cost Effectiveness and Resource Allocation, 2015 - Springer
Objective The purpose of this study was to assess the consequences of a national
immunization program with HPV vaccine for both boys and girls in Denmark, including the …
immunization program with HPV vaccine for both boys and girls in Denmark, including the …
[HTML][HTML] Epidemiologic and economic burden of HPV diseases in Spain: implication of additional 5 types from the 9-valent vaccine
N López, A Torné, A Franco, M San-Martin… - Infectious agents and …, 2018 - Springer
Background A new nonavalent human papillomavirus (HPV) vaccine that includes
genotypes 6/11/16/18/31/33/45/52/58 has been recently approved in Spain. A previous …
genotypes 6/11/16/18/31/33/45/52/58 has been recently approved in Spain. A previous …
Economic burden of HPV-related cancers in France
I Borget, L Abramowitz, P Mathevet - Vaccine, 2011 - Elsevier
Human papillomavirus (HPV) infection is associated with a range of diseases and cancers at
different anatomical sites. In addition to its role as a necessary cause of cervical cancer, HPV …
different anatomical sites. In addition to its role as a necessary cause of cervical cancer, HPV …